September 14, 2021

Event | Café Croissant with BIOQuebéc

BIOQuébec is proud to announce a new partnership with Bloom Burton & Co.

Café Croissant is a four-part webinar series on biotech and healthcare finance. Three other thematic meetings are scheduled to take place in the fall.

About BIOQuébec
BIOQuébec is committed to supporting Québec’s biotechnology and life sciences industry, which creates wealth and specialized jobs, is focused on innovation and marketing, and is dedicated to improving everyone’s health and quality of life.

BIOQuébec’s membership is comprised of companies and organizations which operate at every level of the biotechnology and life sciences innovation sector. They are active in researching, developing, and marketing new tests, drugs, and other life sciences-related products and services.

Registration for Café Croissant with BIOQuebéc
FREE FOR BIOQuébec MEMBERS, $25 FOR NON-MEMBERS
*BioForward Wisconsin members, please send an email to lgagnon@bioquebec.com to register. Is my organization a member? Click here to find out

JUNE 3, 2021 AT 8:15-9:15AM ET  |  WEBINAR  |  PAST EVENT

Bloom Burton – Learn more about Bloom Burton & Co. Find out how you can work with the organization and what they can do for your business.

SEPTEMBER 29, 2021 AT 8:00-9:30 AM ET |  WEBINAR  |  REGISTRATION OPEN

How Investors Evaluate Biotech Companies – What are the most important things investors consider when making an investment? How do they really approach the due diligence process, valuation, governance and structure?

Come and meet Brian Bloom and Vincent Nadeau to gain insight on how to position and articulate your investment opportunity and close your next financing round. Presentation in English

OCTOBER 27, 2021 AT 8:00-9:30 AM ET |  WEBINAR  |  REGISTRATION OPEN

The Public Market Option for Venture-Stage Companies – Going public on a Canadian stock exchange can be a viable financing option for venture-stage biotechnology companies. In certain situations, this route can lead to larger financings in Canada, participation from U.S. institutional investors, and an eventual NASDAQ listing.

Join Brian Bloom and Vincent Nadeau to learn if this strategy is a fit for your company. Presentation in English

DECEMBER 8, 2021 AT 8:30-10:00 AM ET |  WEBINAR  |  REGISTRATION OPEN UNTIL DEC. 6

2021 Biotechnology Financing Year In Review and 2022 Preview –  How was 2021 for Canadian and global biotech financings? Which companies performed and which did not? What can we learn from 2021 and predict for 2022? What are the biggest milestones and what can we learn from them?

Register for the final Café Croissant of 2021 to hear Brian Bloom, David Martin, and Vincent Nadeau present an overview of the Canadian capital markets. Presentation in English